Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Venture Life (GB:VLG)
:VLG
Holding GB:VLG?
Track your performance easily
VLG Stock Chart & Stats
Day’s Range― - ―
52-Week Range33.00p - 51.29p
Previous CloseN/A
Volume16.34K
Average Volume (3M)232.72K
Market Cap
£46.37M
Enterprise Value72.51M
Total Cash (Recent Filing)$2.00M
Total Debt (Recent Filing)$6.23M
Price to Earnings (P/E)68.8
Beta0.55
Next Earnings
Apr 09, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 24, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding127,052,315
10 Day Avg. Volume219,158
30 Day Avg. Volume232,724
Standard Deviation0.17
R-Squared0.00531
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.46
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.56
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.10
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Venture Life News
PremiumCompany Announcements
Slater Investments Increases Stake in Venture Life Group
PremiumCompany Announcements
Venture Life Group Sees Change in Voting Rights
PremiumCompany Announcements
Venture Life Chairman Increases Shareholding Stake
PremiumCompany Announcements
Venture Life Director Increases Stake with Major Share Purchase
PremiumCompany Announcements
Slater Investments Ups Stake in Venture Life Group
PremiumCompany Announcements
Venture Life Stays Strong with Brand GrowthPremiumCompany Announcements
Venture Life Hosts Investor Presentation EventPremiumCompany Announcements
Venture Life Executives Sell Shares for TaxesOptions Prices
Currently, No data available
---
Ownership Overview
VLG FAQ
What was Venture Life’s price range in the past 12 months?
Venture Life lowest share price was 33.00p and its highest was 51.29p in the past 12 months.
What is Venture Life’s market cap?
Venture Life’s market cap is £46.37M.
When is Venture Life’s upcoming earnings report date?
Venture Life’s upcoming earnings report date is Apr 09, 2025 which is in 77 days.
How were Venture Life’s earnings last quarter?
Venture Life released its earnings results on Sep 30, 2024. The company reported 0.004p earnings per share for the quarter, beating the consensus estimate of N/A by 0.004p.
Is Venture Life overvalued?
According to Wall Street analysts Venture Life’s price is currently Overvalued.
Does Venture Life pay dividends?
Venture Life pays a Annually dividend of 0p which represents an annual dividend yield of N/A. See more information on Venture Life dividends here
What is Venture Life’s EPS estimate?
Venture Life’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Venture Life have?
Venture Life has 127,052,315 shares outstanding.
What happened to Venture Life’s price movement after its last earnings report?
Venture Life reported an EPS of 0.004p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of Venture Life?
Currently, no hedge funds are holding shares in GB:VLG
---
Venture Life Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth £99.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
5.79%
12-Months-Change
Fundamentals
Return on Equity
1.00%
Trailing 12-Months
Asset Growth
-2.08%
Trailing 12-Months
Company Description
Venture Life
Venture Life Group PLC is an international consumer self-care company. The company focuses on developing, manufacturing and commercializing products for the aging population. Its products include Oral Healthcare, Proctology, Dermatology, Neurology, and Women's Healthcare. Its segments include Brands, which includes sales of branded healthcare and cosmetics products direct to retailers and under distribution agreements; and Development and Manufacturing, which includes sales of products and services under contract development and manufacturing agreements. It earns a vast majority of its revenue from the Development and Manufacturing segment in the United Kingdom. Geographically, it also operates in Italy, Switzerland, and other regions.
---
Technical Analysis
---